Source: Breathe 2010; 7: 89



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bush, F.M. de Benedictis. Great clinical trial, flawed editorial response. Breathe 2010; 7: 89

Member's Comments

No comment yet.

Related content which might interest you: Clinical trials during the COVID-19 pandemic: research design and lessons Source: Eur Respir Monogr 2021; 94: 214-231 Year: 2021 New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014 Thoracic oncology, this journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data Source: Journal Club 2022 Year: 2022 Clinical case discussion: How clinical trials inform antibiotic stewardship Source: ERS webinar 2022: Clinical case discussion: How clinical trials inform antibiotic stewardship Year: 2022 A program for clinical and economic governance of long term oxigen therapy (LTOT) in North Italy: methodological issue and preliminary results Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors Year: 2008 A systematic review of clinical trial registration in major respiratory journals 2010–2018 Source: Eur Respir J, 52 (6) 1801491; 10.1183/13993003.01491-2018 Year: 2018 Are we prepared? The PREPARE outbreak clinical research plan Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage Year: 2017 Patient perspective of participation in COVID-19 clinical trials Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 The best papers in the ERJ: clinical practice Source: Virtual Congress 2021 – The best of the European Respiratory Journal 2021 Year: 2021 Lightning lecture: Clinical and scientific work from a clinical perspective Source: International Congress 2016 – PD9 Combining the clinic and research Year: 2016 Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014 Key ongoing issues in trial design Source: Eur Respir Monogr 2016; 71: 253-259 Year: 2016 Validation of the codex index in patients with COPD enrolled in randomized clinical trials: A post-hoc analysis of the trilogy, trinity and tribute studies. Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease Year: 2010 Cough clinical practice guidelines: A critical review of scientific evidence and recommendations Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016